Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer

Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer

Xiao-qing Jia,1 Qi Hong,1 Jing-yi Cheng,2 Jian-wei Li,1 Yu-jie Wang,1 Miao Mo,3 Zhi-min Shao,1 Zhen-zhou Shen,1 Guang-yu Liu1 1Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical Colle...

Full description

Bibliographic Details
Main Authors:	Jia XQ, Hong Q, Cheng JY, Li JW, Wang YJ, Mo M, Shao ZM, Shen ZZ, Liu GY
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-03-01
Series:	OncoTargets and Therapy
Online Access:	http://www.dovepress.com/accumulation-of-p53-is-prognostic-for-aromatase-inhibitor-resistance-i-peer-reviewed-article-OTT

Similar Items

Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor
by: Somsri Wiwanitkit, et al.
Published: (2013-06-01)

Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients
by: Qiong Gao, et al.
Published: (2019-12-01)

Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
by: Margarida Maria Duarte da Silva Cepa
Published: (2019)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
by: Junmei Cairns, et al.
Published: (2020-08-01)

Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
by: Margarida Cepa, et al.
Published: (2015-10-01)

Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
by: Sasagu Kurozumi, et al.
Published: (2018-01-01)

Effects of aromatase inhibitors on aromatase in breast
by: Vidya, Raghavan
Published: (2009)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
by: Stefano Gonnelli, et al.
Published: (2008-12-01)

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
by: Sun SL, et al.
Published: (2016-10-01)

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients
by: Camille Moreau-Bachelard, et al.
Published: (2020-12-01)

Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study
by: Xue Wang, et al.
Published: (2020-05-01)

Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.
by: Gabriella Martino, et al.
Published: (2020-01-01)

Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC
by: Patricia A. Young, MD, et al.
Published: (2021-04-01)

CORRIGENDUM to “Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study”
Published: (2020-08-01)

Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study
by: Alessandro Rossini, et al.
Published: (2020-01-01)

A comparison of the third-generation aromatase inhibitors and their effects on postmenopausal women with early hormone sensitive breast cancer
by: McCaig, Fiona M.
Published: (2012)

Aromatase inhibitors in the treatment of endometriosis
by: Radosław Słopień, et al.
Published: (2016-03-01)

Molecular Docking of Aromatase Inhibitors
by: Virapong Prachayasittikul, et al.
Published: (2011-04-01)

Aromatase inhibitors in male sex
by: Santosh Kumar Singh
Published: (2013-01-01)

Natural Inhibitors of the Aromatase Enzyme
by: Roberto R. Gil
Published: (2000-03-01)

Obesity and postmenopausal breast cancer : determining the role of local aromatase expression
by: Bowers, Laura Wells
Published: (2014)

The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue
by: D. V. Lytkin, et al.
Published: (2018-08-01)

Are another 5 years of adjuvant aromatase inhibitor therapy needed?
by: Mo QG, et al.
Published: (2016-11-01)

Aromatase inhibitors in the treatment of deep endometriosis
by: Simone Ferrero, et al.
Published: (2009-09-01)

Aromatase inhibitors in stimulated IVF cycles
by: Tournaye Herman, et al.
Published: (2011-06-01)

Aromatase inhibitors in post-menopausal endometriosis
by: Devroey Paul, et al.
Published: (2011-06-01)

Synthesis and evaluation of potential aromatase inhibitors
by: Nazareth, W. M. A.
Published: (1988)

Synthetic methodology towards inhibitors of aromatase
by: Hares, Owen
Published: (1990)

Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
by: Michael Dieckmeyer, et al.
Published: (2019-11-01)

Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormone-sensitive early breast cancer: a case study
by: Bryce J, et al.
Published: (2012-03-01)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
by: Swaathi Jayaraman, et al.
Published: (2020-05-01)

Computational investigations of cytochrome P450 aromatase catalysis and biological evaluation of isoflavone aromatase inhibitors
by: Hackett, John C.
Published: (2004)

The emerging use of aromatase inhibitors for endometriosis treatment
by: Nothnick Warren B
Published: (2011-06-01)

Aromatase inhibitors in men: effects and therapeutic options
by: de Jong Frank H, et al.
Published: (2011-06-01)

Potential role of aromatase inhibitors in the treatment of endometriosis
by: Abu Hashim H
Published: (2014-07-01)

Evaluation of Arthralgia Induced by Aromatase Inhibitor Therapy
by: Gulabi Mese, et al.
Published: (2013-02-01)

Aromatase inhibitor strategies in metastatic breast cancer
by: Heather L McArthur, et al.
Published: (2009-07-01)

Toxicological and pharmacological aspects of some aromatase inhibitors
by: Khalaf, Laila Fadhel
Published: (1993)

Clinical utilities of aromatase inhibitors in breast cancer
by: Chumsri S
Published: (2015-05-01)

Investigating the effects of aromatase inhibitors on the musculoskeletal system
by: Shujja-Ud-Din, Omar S.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ervuo5r506jdfbqg6uqujuivpp